Globus Medical Total Liabilities 2010-2024 | GMED

Globus Medical total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Globus Medical total liabilities for the quarter ending September 30, 2024 were $1.017B, a 13% decline year-over-year.
  • Globus Medical total liabilities for 2023 were $1.088B, a 373.61% increase from 2022.
  • Globus Medical total liabilities for 2022 were $0.23B, a 6.43% increase from 2021.
  • Globus Medical total liabilities for 2021 were $0.216B, a 24.65% increase from 2020.
Globus Medical Annual Total Liabilities
(Millions of US $)
2023 $1,088
2022 $230
2021 $216
2020 $173
2019 $130
2018 $115
2017 $111
2016 $96
2015 $119
2014 $118
2013 $94
2012 $61
2011 $47
2010 $38
2009 $0
Globus Medical Quarterly Total Liabilities
(Millions of US $)
2024-09-30 $1,017
2024-06-30 $1,017
2024-03-31 $1,021
2023-12-31 $1,088
2023-09-30 $1,169
2023-06-30 $227
2023-03-31 $235
2022-12-31 $230
2022-09-30 $212
2022-06-30 $216
2022-03-31 $213
2021-12-31 $216
2021-09-30 $192
2021-06-30 $191
2021-03-31 $175
2020-12-31 $173
2020-09-30 $125
2020-06-30 $129
2020-03-31 $116
2019-12-31 $130
2019-09-30 $113
2019-06-30 $103
2019-03-31 $99
2018-12-31 $115
2018-09-30 $97
2018-06-30 $97
2018-03-31 $101
2017-12-31 $111
2017-09-30 $102
2017-06-30 $90
2017-03-31 $92
2016-12-31 $96
2016-09-30 $92
2016-06-30 $90
2016-03-31 $91
2015-12-31 $119
2015-09-30 $127
2015-06-30 $122
2015-03-31 $130
2014-12-31 $118
2014-09-30 $93
2014-06-30 $90
2014-03-31 $97
2013-12-31 $94
2013-09-30 $76
2013-06-30 $76
2013-03-31 $65
2012-12-31 $61
2012-09-30 $52
2012-06-30 $46
2012-03-31 $53
2011-12-31 $47
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $38
2009-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $12.707B $1.568B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $219.781B 26.81
Intuitive Surgical (ISRG) United States $217.430B 113.68
Alcon (ALC) Switzerland $43.790B 29.30
Edwards Lifesciences (EW) United States $40.720B 25.86
IQVIA Holdings (IQV) United States $37.284B 20.54
IDEXX Laboratories (IDXX) United States $35.259B 41.52
DexCom (DXCM) United States $34.017B 51.23
Waters (WAT) United States $24.246B 35.85
STERIS (STE) Ireland $21.575B 24.84
SONOVA HOLDING (SONVY) Switzerland $20.893B 0.00
Hologic (HOLX) United States $16.069B 17.45
Fresenius Medical Care AG KGaA (FMS) Germany $13.597B 13.96
Sysmex ADR (SSMXY) Japan $11.852B 37.16
Penumbra (PEN) United States $10.587B 103.70
Masimo (MASI) United States $9.271B 44.86
Glaukos (GKOS) United States $8.829B 0.00
Teleflex (TFX) United States $8.395B 13.39
Integer Holdings (ITGR) United States $4.744B 26.89
Inari Medical (NARI) United States $4.650B 0.00
PROCEPT BioRobotics (PRCT) United States $3.570B 0.00
Veracyte (VCYT) United States $3.336B 100.12
LivaNova (LIVN) United Kingdom $2.642B 15.25
Nihon Kohden (NHNKY) Japan $2.325B 17.66
Tandem Diabetes Care (TNDM) United States $2.299B 0.00
Elekta AB (EKTAY) Sweden $2.235B 20.10
TransMedics (TMDX) United States $2.080B 65.93
Integra LifeSciences Holdings (IART) United States $1.918B 10.02
Alphatec Holdings (ATEC) United States $1.614B 0.00
Artivion (AORT) United States $1.290B 85.50
RxSight (RXST) United States $1.286B 0.00
Pulse Biosciences (PLSE) United States $1.152B 0.00
OPKO Health (OPK) United States $1.003B 0.00
Paragon 28 (FNA) United States $0.979B 0.00
AxoGen (AXGN) United States $0.831B 0.00
Mesa Laboratories (MLAB) United States $0.787B 18.55
IRadimed (IRMD) United States $0.752B 40.63
AVANOS MEDICAL, INC (AVNS) United States $0.729B 12.39
ORTHOFIX MEDICAL INC (OFIX) United States $0.702B 0.00
SiBone (SIBN) United States $0.698B 0.00
OrthoPediatrics (KIDS) United States $0.657B 0.00
Treace Medical Concepts (TMCI) United States $0.587B 0.00
Semler Scientific (SMLR) United States $0.576B 30.30
Pacific Biosciences Of California (PACB) United States $0.496B 0.00
ClearPoint Neuro (CLPT) United States $0.494B 0.00
AngioDynamics (ANGO) United States $0.488B 0.00
Delcath Systems (DCTH) United States $0.486B 0.00
NeuroPace (NPCE) United States $0.419B 0.00
CVRx (CVRX) United States $0.418B 0.00
Tactile Systems Technology (TCMD) United States $0.417B 22.57
Alpha Tau Medical (DRTS) Israel $0.279B 0.00
Inogen (INGN) United States $0.258B 0.00
Accuray (ARAY) United States $0.229B 0.00
Anteris Technologies Global (AVR) Australia $0.215B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
Nevro (NVRO) United States $0.184B 0.00
Sight Sciences (SGHT) United States $0.146B 0.00
Atossa Genetics (ATOS) United States $0.120B 0.00
Sensus Healthcare (SRTS) United States $0.115B 12.26
Monogram Orthopaedics (MGRM) United States $0.098B 0.00
908 Devices (MASS) United States $0.098B 0.00
LENSAR (LNSR) United States $0.097B 0.00
Spectral Diagnostics (EDTXF) Canada $0.097B 0.00
EDAP TMS S.A (EDAP) France $0.084B 0.00
Vicarious Surgical (RBOT) United States $0.083B 0.00
WORK Medical Technology Group (WOK) China $0.076B 0.00
InspireMD (NSPR) Israel $0.072B 0.00
Neuronetics (STIM) United States $0.071B 0.00
Hyperfine (HYPR) United States $0.068B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
Rapid Micro Biosystems (RPID) United States $0.061B 0.00
Covalon Technologies (CVALF) Canada $0.059B 30.86
Lucid Diagnostics (LUCD) United States $0.049B 0.00
Baird Medical Investment Holdings (BDMD) $0.046B 0.00
Microbot Medical (MBOT) United States $0.040B 0.00
Spectral AI (MDAI) United States $0.038B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.031B 0.00
Accelerate Diagnostics (AXDX) United States $0.028B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
NexGel (NXGL) United States $0.022B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.014B 0.00
QT Imaging Holdings (QTI) United States $0.014B 0.00
Adagio Medical Holdings (ADGM) United States $0.012B 0.00
Check-Cap (CHEK) Israel $0.008B 0.00
Aspira Women's Health (AWH) United States $0.007B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
T2 Biosystems (TTOO) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00